Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arlene Sharpe

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Proceedings of the National Academy of Sciences of the United States of America|January 11, 2005
Epstein-Barr virus nuclear antigen 1 does not induce lymphoma in transgenic FVB miceMyung-Soo Kang, Hongxiang Lu, Teruhito Yasui, et al.
Gastroenterology|February 14, 2006
CD48 controls T-cell and antigen-presenting cell functions in experimental colitisAna C Abadía-Molina, Honbing Ji, William A Faubion, et al.
International Immunology|September 12, 2013
DEC-205-mediated antigen targeting to steady-state dendritic cells induces deletion of diabetogenic CD8⁺ T cells independently of PD-1 and PD-L1Gayatri Mukherjee, Ari Geliebter, Jeffrey Babad, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 3, 2012
Crucial role of granulocytic myeloid-derived suppressor cells in the regulation of central nervous system autoimmune diseaseMarianna Ioannou, Themis Alissafi, Iakovos Lazaridis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 25, 2003
Cutting edge: transplantation tolerance through enhanced CTLA-4 expressionCharlotte Ariyan, Paolo Salvalaggio, Scott Fecteau, et al.
Infection and Immunity|October 15, 2014
Transgenic expression of CXCR3 on T cells enhances susceptibility to cutaneous Leishmania major infection by inhibiting monocyte maturation and promoting a Th2 responseSteve Oghumu, James C Stock, Sanjay Varikuti, et al.
Nature Medicine|January 26, 2023
Combined PD-1, BRAF and MEK inhibition in BRAF<sup>V600E</sup> colorectal cancer: a phase 2 trialJun Tian, Jonathan H Chen, Sherry X Chao, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Proceedings of the National Academy of Sciences of the United States of America|January 11, 2005
Epstein-Barr virus nuclear antigen 1 does not induce lymphoma in transgenic FVB miceMyung-Soo Kang, Hongxiang Lu, Teruhito Yasui, et al.
Gastroenterology|February 14, 2006
CD48 controls T-cell and antigen-presenting cell functions in experimental colitisAna C Abadía-Molina, Honbing Ji, William A Faubion, et al.
International Immunology|September 12, 2013
DEC-205-mediated antigen targeting to steady-state dendritic cells induces deletion of diabetogenic CD8⁺ T cells independently of PD-1 and PD-L1Gayatri Mukherjee, Ari Geliebter, Jeffrey Babad, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 3, 2012
Crucial role of granulocytic myeloid-derived suppressor cells in the regulation of central nervous system autoimmune diseaseMarianna Ioannou, Themis Alissafi, Iakovos Lazaridis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 25, 2003
Cutting edge: transplantation tolerance through enhanced CTLA-4 expressionCharlotte Ariyan, Paolo Salvalaggio, Scott Fecteau, et al.
Infection and Immunity|October 15, 2014
Transgenic expression of CXCR3 on T cells enhances susceptibility to cutaneous Leishmania major infection by inhibiting monocyte maturation and promoting a Th2 responseSteve Oghumu, James C Stock, Sanjay Varikuti, et al.
Nature Medicine|January 26, 2023
Combined PD-1, BRAF and MEK inhibition in BRAF<sup>V600E</sup> colorectal cancer: a phase 2 trialJun Tian, Jonathan H Chen, Sherry X Chao, et al.
Pageof 2